A. Gómez-Mejia
发表
M. Rohde,
Stephanie Hirschmann,
A. Gómez-Mejia,
2021,
Microorganisms.
D. Becher,
M. Rohde,
A. Gómez-Mejia,
2020,
Frontiers in Microbiology.
L. Risch,
P. Vernazza,
J. Penninger,
2020,
Clinical Infectious Diseases.
L. Risch,
P. Vernazza,
J. Penninger,
2020,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
A. Gómez-Mejia,
S. Hammerschmidt,
G. Gámez,
2021,
Journal of Pediatric Infectious Diseases.
A. Gómez-Mejia,
S. Hammerschmidt,
G. Gámez,
2020
.
R. Zbinden,
A. Gómez-Mejia,
B. Hasse,
2021,
bioRxiv.
A. Gómez-Mejia,
S. Brugger,
M. Huemer,
2020,
bioRxiv.
D. Driesch,
M. Rohde,
U. Mäder,
2021,
Microorganisms.
L. Risch,
P. Vernazza,
J. Penninger,
2020,
medRxiv.
H. Moch,
A. Gómez-Mejia,
S. Hoeller,
2021,
Clinical & translational immunology.
D. Becher,
M. Rohde,
A. Gómez-Mejia,
2020,
Frontiers in Microbiology.
M. Lalk,
A. Gómez-Mejia,
S. Hammerschmidt,
2018,
International journal of medical microbiology : IJMM.
Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae
D. Schwudke,
M. Rohde,
B. Kreikemeyer,
2017,
Nature Communications.
R. Kouyos,
A. Gómez-Mejia,
B. Hasse,
2022,
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
A. Gómez-Mejia,
F. Andreoni,
R. Schuepbach,
2022,
bioRxiv.
D. Bumann,
A. Gómez-Mejia,
B. Hasse,
2021,
Proceedings of the National Academy of Sciences.
R. Zbinden,
A. Gómez-Mejia,
B. Hasse,
2021,
Antimicrobial agents and chemotherapy.
J. Dworkin,
S. Pereira,
A. Gómez-Mejia,
2023,
Science Signaling.
J. Dworkin,
S. Pereira,
A. Gómez-Mejia,
2021,
bioRxiv.
Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae
D. Schwudke,
M. Rohde,
B. Kreikemeyer,
2017,
Nature Communications.
F. Gago,
D. Pantoja-Uceda,
J. Hermoso,
2016,
Scientific Reports.
D. Becher,
M. Rohde,
A. Gómez-Mejia,
2018,
International journal of medical microbiology : IJMM.
A. Gómez-Mejia,
R. Schuepbach,
A. Zinkernagel,
2022,
PLoS pathogens.
Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patients
H. Moch,
A. Gómez-Mejia,
S. Hoeller,
2021,
bioRxiv.
A. Gómez-Mejia,
S. Hammerschmidt,
G. Gámez,
2017,
International journal of medical microbiology : IJMM.
A. Gómez-Mejia,
S. Hammerschmidt,
G. Gámez,
2018,
BMC Genomics.
P. Sinues,
A. Gómez-Mejia,
A. Zinkernagel,
2022,
bioRxiv.
A. Gómez-Mejia,
S. Hammerschmidt,
G. Gámez,
2018,
BMC Genomics.
R. Moritz,
U. Völker,
A. Gómez-Mejia,
2019,
PLoS pathogens.
A. Gómez-Mejia,
F. Andreoni,
R. Schuepbach,
2021,
Cell Reports Medicine.
A. Gómez-Mejia,
A. Güitrón,
M. Macías,
1995,
Revista de gastroenterologia de Mexico.
R. Kouyos,
A. Gómez-Mejia,
B. Hasse,
2021,
bioRxiv.
A. Gómez-Mejia,
F. Andreoni,
R. Schuepbach,
2020,
medRxiv.
U. Völker,
U. Mäder,
Stephanie Hirschmann,
2018,
mSphere.
U. Völker,
U. Mäder,
Stephanie Hirschmann,
2018,
bioRxiv.
C. Muskus,
J. Hermoso,
A. Gómez-Mejia,
2021,
bioRxiv.
L. Risch,
P. Vernazza,
A. Bergthaler,
2021
.